Bortezomib does not reduce ABO-isoagglutinin titers and may not be useful for ABO-incompatible transplant desensitization.

Raghavender Boothpur, Stephanie Torrence, Daniel C. Brennan

Research output: Contribution to journalArticle

Original languageEnglish (US)
Pages (from-to)491-493
Number of pages3
JournalClinical transplants
StatePublished - 2009
Externally publishedYes

ASJC Scopus subject areas

  • Medicine(all)

Cite this